Simultaneous Analysis of Fluoxetine, Norfluoxetine, Citalopram, and Haloperidol in Plasma by LC-ESI-IT-MS

被引:8
作者
El-Rjoob, Abdul-Wahab [1 ]
Tahtamouni, Munther [2 ]
Tahboub, Yahya R. [1 ,2 ]
机构
[1] Jordan Univ Sci & Technol, Dept Appl Chem, Irbid 22110, Jordan
[2] Jordan Univ Sci & Technol, Princess Haya Ctr Biotechnol, Irbid 22110, Jordan
关键词
Column liquid chromatography-mass spectrometry; Fluoxetine; Norfluoxetine; Citalopram; Haloperidol; CHROMATOGRAPHY-MASS SPECTROMETRY; LIQUID-CHROMATOGRAPHY; FLUORESCENCE DETECTION; FORENSIC TOXICOLOGY; METABOLITES; DRUGS; BLOOD; MS/MS;
D O I
10.1365/s10337-010-1483-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A reliable and simple method has been developed for simultaneous analysis of fluoxetine, its metabolite norfluoxetine, citalopram, and haloperidol with lamotrigine as internal standard. The method is based on solid-phase extraction on mixed-mode cation-exchange cartridges followed by LC separation on a C-18 column at ambient temperature with a gradient prepared from acetonitrile and 5 mM ammonium acetate in 0.1% (v/v) aqueous formic acid. The flow rate was 0.5 mL min(-1). Eluted compounds were ionized by the electrospray ionization ion source of an ion-trap mass spectrometer and were detected by selected ion monitoring. Co-extracted endogenous compounds from plasma were eluted in the first 5 min and discarded by valve-switching. The target drugs were eluted in the period 5.5-11 min. Calibration plots were linear in the ranges 5 (or 10)-400 ng mL(-1) with correlation coefficients > 0.999. Other statistical and validation results were within accepted ranges for clinical analysis.
引用
收藏
页码:423 / 430
页数:8
相关论文
共 23 条
  • [1] [Anonymous], 2001, Guidance for industry, bioanalytical method validation
  • [2] The AGNP-TDM expert group consensus guidelines:: Therapeutic Drug Monitoring in psychiatry
    Baumann, P
    Hiemke, C
    Ulrich, S
    Eckermann, G
    Gaertner, I
    Gerlach, M
    Kuss, HJ
    Laux, G
    Müller-Oerlinghausen, B
    Rao, ML
    Riederer, P
    Zernig, G
    [J]. PHARMACOPSYCHIATRY, 2004, 37 (06) : 243 - 265
  • [3] COGTATAY N, 2001, BR J CLIN PHARM, V52, P103, DOI DOI 10.1111/J.1365-2125.2001.00088.X
  • [4] Recent developments in analytical ion trap mass spectrometry
    Creaser, CS
    Stygall, JW
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 1998, 17 (10) : 583 - 593
  • [5] LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma -: Study of correlation between venlafaxine concentrations in both matrices
    de Castro, A.
    Concheiro, M.
    Quintela, O.
    Cruz, A.
    Lopez-Rivadulla, M.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 48 (01) : 183 - 193
  • [6] EFFECT OF HALOPERIDOL AND ITS METABOLITES ON DOPAMINE AND NORADRENALINE UPTAKE IN RAT BRAIN-SLICES
    FANG, J
    YU, PH
    [J]. PSYCHOPHARMACOLOGY, 1995, 121 (03) : 379 - 384
  • [7] FURUKORI N, 2004, J CHROMATOGR B, V805, P175, DOI DOI 10.1016/J.JCHROMB.2004.02.043
  • [8] Multidimensional on-line SPE for undisturbed LC-MS-MS analysis of basic drugs in biofluids
    Georgi, K.
    Boos, K. -S.
    [J]. CHROMATOGRAPHIA, 2006, 63 (11-12) : 523 - 531
  • [9] Gross AS, 2001, BRIT J CLIN PHARMACO, V52, p5S
  • [10] Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis
    Hall, WD
    Mant, A
    Mitchell, PB
    Rendle, VA
    Hickie, IB
    McManus, P
    [J]. BRITISH MEDICAL JOURNAL, 2003, 326 (7397): : 1008 - 1011